The Federal Drug Administration (FDA) has approved a new once-daily weight-loss pill from Eli Lilly, adding to the bevy of GLP-1 medications available in the consumer marketplace. The drug manufacturer announced on Tuesday that the company would begin shipping orforglipron, branded as Foundayo, as soon as Monday following approval from federal regulators. Prescribed as a…
Trending
- Amidst conflicting signals, Trump addresses nation on Iran war
- Zelenskyy cites progress on security deal after call with Trump envoys
- Republicans in Congress say they have a deal to end the record-long shutdown at DHS : NPR
- 2026 ANWA leaderboard: Maria Jose Marin, Soomin Oh tied on top after first round
- Macquarie bets impact investing can fill an Asian finance gap
- Man sentenced in cross burning hoax to help elect Colorado Springs’ first Black mayor
- Stephen A Smith says he regrets voting for Kamala Harris on Sage Steele show
- College baseball Week 7: Top-25 rankings, best moments and what to watch
Wednesday, April 1
